Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Cardiology

Moving Toward Treatment: Repair, Replacement, and Timing

At a Glance

For mitral valve prolapse with chronic severe regurgitation, treatment is usually recommended when symptoms develop or heart function begins to decline. Durable surgical repair is preferred when feasible; valve replacement or catheter-based TEER may be considered based on anatomy and surgical risk.

For most people with Mitral Valve Prolapse (MVP), the condition never requires more than periodic monitoring. However, if the valve begins to leak significantly (Severe Primary Mitral Regurgitation), the heart can eventually become strained. When this happens, modern medicine offers highly effective treatments designed to fix the valve and protect your heart’s long-term function [1][2].

Knowing When It’s Time: The Surgical “Triggers”

Cardiologists follow international guidelines to determine the best moment for surgery. For chronic severe primary MR, the goal is to intervene before the heart muscle sustains permanent damage [3]. The highest-priority (Class I) triggers for surgery include [4][1]:

  • Symptoms: Any new or worsening shortness of breath, fatigue, or decreased exercise tolerance caused by the severe leak [1].
  • The 60/40 Rule (Asymptomatic): Even if you feel fine, surgery is clearly indicated if your LVEF (pumping strength) drops to 60% or lower, or if your LVESD (left-ventricular end-systolic diameter) reaches 40mm or higher [3][4].

Additional factors that support early surgery include new-onset Atrial Fibrillation or elevated blood pressure in the lungs (Pulmonary Hypertension). A valve team decision determines intervention by integrating these thresholds with your operative risk and the likelihood of a durable repair [4][5].

Why “Repair” is Often Preferred over “Replacement”

If you need surgery for degenerative MVP, Mitral Valve Repair is preferred over replacing the valve with an artificial one—when a durable repair is highly likely [2].

  1. Outcomes: In highly selected cases at experienced centers, patients who receive a successful repair can have excellent long-term survival, whereas replacement carries different risk profiles [6][7].
  2. Heart Strength: Keeping your natural valve structure helps maintain the heart’s natural pumping shape [8].
  3. Blood Thinners: A successful repair usually avoids the need for lifelong anticoagulation solely for the valve (unlike mechanical replacement), though short-term antithrombotic therapy may be used, and lifelong blood thinners might still be needed if you have atrial fibrillation [9].
  4. Durability: Modern repairs can be highly durable, but reoperation risk varies depending on your anatomy, the surgeon, and the center [10][11]. In some complex anatomies, replacement may actually be the safer or more durable option.

The Importance of a “Reference Center”

The success of a mitral valve repair is highly dependent on the skill of the surgeon and the experience of the hospital. Observational data indicates that surgeons with higher volumes have significantly better repair success rates and lower risk-adjusted operative mortality [12][13].

When choosing where to have your surgery, look for an experienced valve center. For degenerative primary MR, benchmarks often look for successful repair rates above 95% and risk-adjusted operative mortality below 1% [14][15]. Keep in mind that quality definitions vary and raw results depend heavily on case mix; do not assume a center is unsafe solely because it does not meet an unqualified number. Focus on finding a surgeon with excellent results for anatomy like yours.

Less Invasive Options: TEER (MitraClip)

For patients with symptomatic severe primary MR who are at high or prohibitive surgical risk (due to frailty or other serious illnesses) and have suitable anatomy, a less invasive option called Transcatheter Edge-to-Edge Repair (TEER)—often known by the brand name MitraClip—may be an option [16][2].

In this procedure, a doctor threads a thin tube through a vein in the leg to the heart and places a small “clip” on the leaking leaflets [17]. While surgery remains preferred for operable patients because it offers greater long-term durability, TEER provides a vital alternative for those who cannot safely undergo a standard operation. Be sure to discuss the risks of residual MR or the potential need for future reintervention with your Heart Team [2][18][19][20].

Common questions in this guide

When does mitral valve prolapse require surgery?
Mitral valve prolapse often needs only regular monitoring. Surgery is generally recommended for chronic severe primary mitral regurgitation when symptoms such as shortness of breath or fatigue develop from the severe leak, or when heart measurements show risk of damage. Important thresholds include a left ventricular ejection fraction (LVEF) of 60% or lower or a left ventricular end-systolic diameter (LVESD) of 40 mm or higher; new atrial fibrillation or pulmonary hypertension can also support earlier treatment.
Why is mitral valve repair often preferred over replacement?
When a durable repair is highly likely, preserving the patient’s own valve can support the heart’s natural shape and usually avoids lifelong blood thinners solely because of the valve. Repair can also have favorable long-term outcomes, although durability depends on the valve anatomy, surgeon, and center. Replacement may be safer or more durable when repair is unlikely to succeed.
How important is surgeon and valve-center experience for mitral repair?
Repair outcomes depend substantially on the surgeon’s experience and the hospital’s volume of mitral repairs. Patients can ask about the surgeon’s results for anatomy like theirs, repair success rates, and risk-adjusted operative mortality. Reported benchmarks for degenerative primary regurgitation often cite repair rates above 95% and risk-adjusted mortality below 1%, but case mix and definitions differ, so numbers should be interpreted in context.
What is TEER or MitraClip, and who may be eligible?
TEER, often called MitraClip, is a catheter-based procedure that places a clip on the leaking mitral valve leaflets through a vein in the leg. It may be considered for people with symptomatic severe primary mitral regurgitation who have high or prohibitive surgical risk and suitable anatomy. Surgery remains preferred for people who can safely undergo an operation because it is generally more durable, and TEER can leave residual leakage or require another procedure.
Will I need blood thinners after mitral valve repair?
A successful mitral valve repair usually does not require lifelong anticoagulation solely because of the repaired valve, although short-term antithrombotic treatment may be prescribed. A person with atrial fibrillation may still need long-term blood thinners for that condition. The exact plan depends on the procedure and individual risks.
What happens if my mitral valve cannot be repaired?
If repair is not feasible, the valve team may discuss a mechanical or bioprosthetic replacement. Mechanical replacement generally requires lifelong anticoagulation, while bioprosthetic valves have different durability and medication considerations. The choice depends on factors such as age, lifestyle, anatomy, and your treatment preferences.

Get notified when new evidence is published on mitral valve prolapse.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (20)
  1. 1

    Myocardial Dysfunction in Primary Mitral Regurgitation: A Review.

    Anand V, Bonow RO, Nishimura RA, et al.

    JAMA cardiology 2026; (11(2)):199-207 doi:10.1001/jamacardio.2025.4561.

    PMID: 41405892
  2. 2

    Acquired Gerbode Defect Diagnosed Seven Years After Surgical Mitral Valve Repair for Severe Primary Mitral Valve Regurgitation: A Case Report.

    Kazma H, Iskandar S, Hitti J, et al.

    Cureus 2025; (17(10)):e94436 doi:10.7759/cureus.94436.

    PMID: 41246616
  3. 3

    Is there a role for biomarkers in asymptomatic severe chronic primary mitral regurgitation?

    Verma R, Bisleri G, Ong G, Connelly KA

    Current opinion in cardiology 2023; (38(2)):68-74 doi:10.1097/HCO.0000000000001016.

    PMID: 36633320
  4. 4

    Survival loss linked to guideline-based indications for degenerative mitral regurgitation surgery.

    Vancraeynest D, Pouleur AC, de Meester C, et al.

    European heart journal. Cardiovascular Imaging 2024; (25(12)):1703-1711 doi:10.1093/ehjci/jeae176.

    PMID: 38996050
  5. 5

    Asymptomatic severe degenerative mitral regurgitation.

    Björn R, Strom JB, Lloyd G, Bhattacharyya S

    Heart (British Cardiac Society) 2024; (111(2)):47-54 doi:10.1136/heartjnl-2024-324739.

    PMID: 39515991
  6. 6

    Twenty-Year Outcome After Mitral Repair Versus Replacement for Severe Degenerative Mitral Regurgitation: Analysis of a Large, Prospective, Multicenter, International Registry.

    Lazam S, Vanoverschelde JL, Tribouilloy C, et al.

    Circulation 2017; (135(5)):410-422 doi:10.1161/CIRCULATIONAHA.116.023340.

    PMID: 27899396
  7. 7

    Comparison of Mitral Valve Replacement and Repair for Degenerative Mitral Regurgitation: a Meta-analysis and Implications for Transcatheter Mitral Procedures.

    Overtchouk P, Ben-Ali W, Prendergast B, et al.

    Current cardiology reports 2020; (22(9)):79 doi:10.1007/s11886-020-01333-x.

    PMID: 32648008
  8. 8

    Mitral Valve Repair vs. Replacement: Hemodynamics in Valve Surgery.

    Zou M, Huang K, Wang X, et al.

    Reviews in cardiovascular medicine 2026; (27(6)):49299 doi:10.31083/RCM49299.

    PMID: 42416560
  9. 9

    On-X mitral valve replacement: a single-centre experience in 318 patients.

    Murana G, Alfonsi J, Savini C, et al.

    Interactive cardiovascular and thoracic surgery 2018; (27(6)):836-841 doi:10.1093/icvts/ivy184.

    PMID: 29901810
  10. 10

    Effect of Recurrent Mitral Regurgitation Following Degenerative Mitral Valve Repair: Long-Term Analysis of Competing Outcomes.

    Suri RM, Clavel MA, Schaff HV, et al.

    Journal of the American College of Cardiology 2016; (67(5)):488-98.

    PMID: 26846946
  11. 11

    Benefits of Early Surgery on Clinical Outcomes After Degenerative Mitral Valve Repair.

    Zhou T, Li J, Lai H, et al.

    The Annals of thoracic surgery 2018; (106(4)):1063-1070 doi:10.1016/j.athoracsur.2018.05.011.

    PMID: 29883645
  12. 12

    Relation of Mitral Valve Surgery Volume to Repair Rate, Durability, and Survival.

    Chikwe J, Toyoda N, Anyanwu AC, et al.

    Journal of the American College of Cardiology 2017; doi:10.1016/j.jacc.2017.02.026.

    PMID: 28476349
  13. 13

    Volume-Outcome Association of Mitral Valve Surgery in the United States.

    Badhwar V, Vemulapalli S, Mack MA, et al.

    JAMA cardiology 2020; (5(10)):1092-1101 doi:10.1001/jamacardio.2020.2221.

    PMID: 32609292
  14. 14

    Transcatheter mitral valve chord repair.

    Savic V, Pozzoli A, Gülmez G, et al.

    Annals of cardiothoracic surgery 2018; (7(6)):731-740 doi:10.21037/acs.2018.09.09.

    PMID: 30598886
  15. 15

    Early and Late Results after Surgical Mitral Valve Repair: A High-Volume Center Experience.

    Götte J, Zittermann A, Deutsch MA, et al.

    The Thoracic and cardiovascular surgeon 2024; (72(8)):624-630 doi:10.1055/a-2266-7677.

    PMID: 38346705
  16. 16

    2025 ESC/EACTS valvular heart disease guidelines: practical updates on mitral and tricuspid regurgitation.

    Adamo M, Massussi M, Marsan NA, et al.

    European heart journal supplements : journal of the European Society of Cardiology 2026; (28(Suppl 4)):iv83-iv96 doi:10.1093/eurheartjsupp/suag001.

    PMID: 42064867
  17. 17

    Transcatheter Mitral Valve Repair for Degenerative Mitral Regurgitation.

    Makkar RR, Chikwe J, Chakravarty T, et al.

    JAMA 2023; (329(20)):1778-1788 doi:10.1001/jama.2023.7089.

    PMID: 37219553
  18. 18

    Transcatheter vs Surgical Mitral Valve Repair in Patients Younger Than 70 Years in the United States.

    Sallam A, Tam DY, Razavi A, et al.

    The Annals of thoracic surgery 2026; doi:10.1016/j.athoracsur.2026.05.061.

    PMID: 42362134
  19. 19

    Advances in Mitral Valve Repair for Degenerative Mitral Regurgitation: Philosophy, Technical Details, and Long-Term Results.

    Del Forno B, Ascione G, De Bonis M

    Cardiology clinics 2021; (39(2)):175-184 doi:10.1016/j.ccl.2021.01.001.

    PMID: 33894931
  20. 20

    Starting A New Robotic Surgery Program for Mitral Valve Repair. Lessons Learned from The First Nine Months.

    Piperata A, Busuttil O, d'Ostrevy N, et al.

    Journal of clinical medicine 2021; (10(22)) doi:10.3390/jcm10225439.

    PMID: 34830720

This page is for informational purposes only and does not constitute medical advice about mitral valve prolapse. Your cardiologist and valve team should interpret your imaging and discuss the safest treatment for you.

Guide contents mitral valve prolapse
Research & Literature
05 Living with MVP